Ramírez NE, Alderete BJ, Romero FJÁ

Language: Spanish
References: 20
Page: 239-245
PDF size: 363.43 Kb.

ABSTRACT

Developmental cortical malformations are frequently related to drug-resistant epilepsies. The objective is we discuss the epileptic hypothesis of the «second hit», in relation to epilepsy and developmental cortical malformations. We report the case of a young adult, with a 15-year follow-up, with a hemispheric and complex cortical malformation. Clinically he is seizures free, in monotherapy. The developmental cortical malformations are proepileptic lesions, a second hit can trigger an epileptic clinical expression with drug-resistant evolution.

REFERENCES

1. Leventer RJ, Scerri T, Marsh APL, Pope K, Gillies G, Maixner W et al. Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR. Neurology. 2015; 84 (20): 2029-2032.

2. Gálvez MM, Rojas CG, Cordovez MJ, Ladrón-de-Guevara D, Campos PM, López SI. Displasias corticales como causa de epilepsia y sus representaciones en las imágenes. Rev Chil Radiol. 2009; 15 (Supl 1): s25-s38.

3. Crino PB. Focal cortical dysplasia. Semin Neurol. 2015; 35 (3): 201-208.

4. Cendes F, Theodore WH, Brinkmann BH, Sulc V, Cascino GD. Neuroimaging of epilepsy. Handb Clin Neurol. 2016; 136: 985-1014.

5. Semah F, Picot C, Adam C, Broglin D, Arzimanoglou A, Bazin B et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998; 51: 1256-1262.

6. Berg AT, Mathern GW, Bronen RA, Fulbright RK, DiMario F, Testa FM et al. Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy. Brain. 2009; 132: 2785-2797.

7. Walker MC, White HS, Sander JW. Disease modification in partial epilepsy. Brain. 2002; 125 (Pt 9): 1937-1950.

8. Romero-Leguizamón CR, Ramírez-Latorre JA, Mora-Muñoz L, Guerrero-Naranjo A. Vías de señalización mTOR y AKT en epilepsia. Rev Neurol. 2016; 63 (1): 33-41.

9. Bockaert J, Marin P. mTOR in brain physiology and pathologies. Physiol Rev. 2015; 95 (4): 1157-1187.

10. Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014; 84 (2): 275-291.

11. Nemes A, Najm I, Gale J, Ying Z, Johnson M, Gonzalez-Martinez J. Underlying cortical dysplasia as risk factor for traumatic epilepsy: an animal study. J Neurotrauma. 2016; 33 (20): 1883-1891.

12. Semple BD, Zamani A, Rayner G, Shultz SR, Jones NC. Affective, neurocognitive and psychosocial disorders associated with traumatic brain injury and post-traumatic epilepsy. Neurobiol Dis. 2019; 123: 27-41.

13. Bickerstaff ER, The basilar artery and the migraine epileptic syndrome. Proc R Soc Med. 1962; 55 (3): 165-176.

14. Baldassari S, Ribierre T, Elise Marsan E, Adle-Biassette H, Ferrand-Sorbets S, Bulteau C et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol. 2019; 138: 885-900.

15. Dawson RE, Nieto Guil AF, Robertson LJ, Piltz SG, Hughes JN, Thomas PQ. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy. Neurobiol Dis. 2020; 134: 104640.

16. Guerrini R, Duchowny M, Jayakar P, Krsek P, Philippe Kahane P, Tassi L et al. Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015; 56 (11): 1669-1686.

17. Ribierre T, Deleuze C, Bacq A, Baldassari S, Marsan E, Chipaux M et al. Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy. J Clin Invest. 2018; 128 (6): 2452-2458.

18. Anderson MP. DEPDC5 takes a second hit in familial focal epilepsy. J Clin Invest. 2018; 128 (6): 2194-2196.

19. Obeid M, Rosenberg EC, Klein PM, Jensen FE. Lestaurtinib (CEP-701) attenuates “second hit” kainic acid-induced seizures following early life hypoxic seizures. Epilepsy Res. 2014; 108 (4): 806-810.

20. Spagnoli C, Cilio MR, Pavlidis E, Pisani F. Symptomatic neonatal seizures followed by febrile status epilepticus: the two-hit hypothesis for the subsequent development of epilepsy. J Child Neurol. 2015; 30 (5): 615-618.